Cargando…

Induced Pluripotent Stem Cell-derived Alveolar Type II Heterogeneity: Revealed by SFTPC Expression

Detalles Bibliográficos
Autor principal:	Mou, Hongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525204/ https://www.ncbi.nlm.nih.gov/pubmed/34153206 http://dx.doi.org/10.1165/rcmb.2021-0242ED

Ejemplares similares

Patient-specific iPSCs carrying an SFTPC mutation reveal the intrinsic alveolar epithelial dysfunction at the inception of interstitial lung disease
por: Alysandratos, Konstantinos-Dionysios, et al.
Publicado: (2021)

Crystal Deposits in Macrophages and Distal Lung Remodeling: A Tale of Aging in SFTPC-Deficient Mice
por: Weng, Tingting, et al.
Publicado: (2020)

Induced pluripotent stem cell-derived lung alveolar epithelial type II cells reduce damage in bleomycin-induced lung fibrosis
por: Alvarez-Palomo, Belén, et al.
Publicado: (2020)

Correlating SFTPC gene variants to interstitial lung disease in Egyptian children
por: Abdel Megeid, Azza K., et al.
Publicado: (2022)

Modeling fibrotic alveolar transitional cells with pluripotent stem cell-derived alveolar organoids
por: Ptasinski, Victoria, et al.
Publicado: (2023)

Human Pluripotent Stem Cell-Derived Alveolar Organoid with Macrophages
por: Seo, Ha-Rim, et al.
Publicado: (2022)

Correction: Correlating SFTPC gene variants to interstitial lung disease in Egyptian children
por: Abdel Megeid, Azza K., et al.
Publicado: (2022)

MicroRNA-22 enhances the differentiation of mouse induced pluripotent stem cells into alveolar epithelial type II cells
por: Tao, Fan, et al.
Publicado: (2020)

Efficient Differentiation of Mouse Induced Pluripotent Stem Cells into Alveolar Epithelium Type II with a BRD4 Inhibitor
por: Momozane, Toru, et al.
Publicado: (2019)

Pluripotent stem cell-derived models of neurological diseases reveal early transcriptional heterogeneity
por: Sorek, Matan, et al.
Publicado: (2021)

Multi-Design Differential Expression Profiling of COVID-19 Lung Autopsy Specimens Reveals Significantly Deregulated Inflammatory Pathways and SFTPC Impaired Transcription
por: Fassan, Matteo, et al.
Publicado: (2022)

Alveolar Macrophage Heterogeneity Goes up in Smoke?
por: Tabary, Mohammadreza, et al.
Publicado: (2022)

An SFTPC gene mutation causes childhood interstitial lung disease: first report in the Arab region
por: Alzaid, Mohammed A, et al.
Publicado: (2020)

Regulation of JAM2 Expression in the Lungs of Streptozotocin-Induced Diabetic Mice and Human Pluripotent Stem Cell-Derived Alveolar Organoids
por: Rasaei, Roya, et al.
Publicado: (2020)

Advances in Induced Pluripotent Stem Cell Technologies
por: Pal, Rajarshi, et al.
Publicado: (2012)

Induced pluripotent stem cells (iPS) derived disease models: In vivo to in vitro gaps
Publicado: (2018)

In Vitro Disease Modeling of Hermansky-Pudlak Syndrome Type 2 Using Human Induced Pluripotent Stem Cell-Derived Alveolar Organoids
por: Korogi, Yohei, et al.
Publicado: (2019)

In Vitro Disease Modeling of Hermansky-Pudlak Syndrome Type 2 Using Human Induced Pluripotent Stem Cell-Derived Alveolar Organoids
por: Korogi, Yohei, et al.
Publicado: (2019)

In vitro modelling of alveolar repair at the air-liquid interface using alveolar epithelial cells derived from human induced pluripotent stem cells
por: van Riet, Sander, et al.
Publicado: (2020)

Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Acquire Rejuvenation and Reduced Heterogeneity
por: Wruck, Wasco, et al.
Publicado: (2021)

Transgene Reactivation in Induced Pluripotent Stem Cell Derivatives and Reversion to Pluripotency of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells
por: Galat, Vasiliy, et al.
Publicado: (2016)

Surfactant Protein C-associated interstitial lung disease; three different phenotypes of the same SFTPC mutation
por: Salerno, Teresa, et al.
Publicado: (2016)

SFTPC genetic polymorphisms are associated with tuberculosis susceptibility and clinical phenotype in a Western Chinese Han population
por: Zhao, Jun-Wei, et al.
Publicado: (2020)

Surfactant Protein C Deficiency in a Puerto Rican Adolescent With a Rare SFTPC Genetic Variant
por: Acosta-Rivera, Victor, et al.
Publicado: (2021)

Towards the safer clinical translation of human induced pluripotent stem cell–derived cells to regenerative medicine
por: Tani, Kenzaburo
Publicado: (2015)

Mind the gap: leak currents and induced pluripotent stem cell–derived cardiomyocytes in translational cardiac electrophysiology
por: Heijman, Jordi, et al.
Publicado: (2023)

Imaging-cytometry revealed spatial heterogeneities of marker expression in undifferentiated human pluripotent stem cells
por: Suga, Mika, et al.
Publicado: (2016)

Acoel single-cell atlas reveals expression dynamics and heterogeneity of adult pluripotent stem cells
por: Hulett, Ryan E., et al.
Publicado: (2023)

Directed induction of alveolar type I cells derived from pluripotent stem cells via Wnt signaling inhibition
por: Kanagaki, Shuhei, et al.
Publicado: (2020)

Generation of human alveolar epithelial type I cells from pluripotent stem cells
por: Burgess, Claire L, et al.
Publicado: (2023)

Abnormal low expression of SFTPC promotes the proliferation of lung adenocarcinoma by enhancing PI3K/AKT/mTOR signaling transduction
por: Zuo, Baile, et al.
Publicado: (2023)

Human pluripotent stem cell-derived alveolar epithelial cells are alternatives for in vitro pulmotoxicity assessment
por: Heo, Hye-Ryeon, et al.
Publicado: (2019)

Human pluripotent stem-cell-derived alveolar organoids for modeling pulmonary fibrosis and drug testing
por: Kim, Jung-Hyun, et al.
Publicado: (2021)

Disease modeling of pulmonary fibrosis using human pluripotent stem cell-derived alveolar organoids
por: Suezawa, Takahiro, et al.
Publicado: (2021)

Pediatric Case Report on an Interstitial Lung Disease with a Novel Mutation of SFTPC Successfully Treated with Lung Transplantation
por: Park, Ji Soo, et al.
Publicado: (2018)

Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC
por: Hosokawa, Motoyasu, et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis with benign SFTPC variant and pathogenic MARS1 mutations: can't see the forest for the trees!
por: Castaldo, Alice, et al.
Publicado: (2023)

Integrative analysis of single-cell RNA-seq and ATAC-seq reveals heterogeneity of induced pluripotent stem cell-derived hepatic organoids
por: Kim, Jong-Hwan, et al.
Publicado: (2023)

Induced pluripotent stem cells as an innovative model to study drug induced pancreatitis
por: Genova, Elena, et al.
Publicado: (2021)

Genetic Association of Pulmonary Surfactant Protein Genes, SFTPA1, SFTPA2, SFTPB, SFTPC, and SFTPD With Cystic Fibrosis
por: Lin, Zhenwu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d9ptqmg6b66588udlvu0s39m0l